CDH2 and cancer: FGFR1–4 can be activated by their ligands, FGFs, and by cell adhesion molecules (CAMs) such as the neural cell adhesion molecule (NCAM), L1-CAM, and N-cadherin to induce specific cell responses and fate during development and cancer [51].